Peoples, C., Medsger, T. A. Jr., Lucas, M., Rosario, B. L. & Feghali-Bostwick, C. A. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J. Scleroderma Relat. Disord. 1, 177–240 (2016).PubMedÂ
Google ScholarÂ
Fan, Y., Bender, S., Shi, W. & Zoz, D. Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States. J. Manag Care Spec. Pharm. 26, 1539–1547 (2020).PubMedÂ
Google ScholarÂ
Ferri, C. et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 81, 139–153 (2002).ArticleÂ
PubMedÂ
Google ScholarÂ
Scussel-Lonzetti, L. et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Med. (Baltim.) 81, 154–167 (2002).ArticleÂ
Google ScholarÂ
Meier, F. M. et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann. Rheum. Dis. 71, 1355–1360 (2012).ArticleÂ
PubMedÂ
Google ScholarÂ
Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557–567 (2007).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Barsotti, S. et al. One year in review 2019: systemic sclerosis. Clin. Exp. Rheumatol. 37, 3–14 (2019).PubMedÂ
Google ScholarÂ
Volkmann, E. R. & Fischer, A. Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease. J. Scleroderma Relat. Disord. 6, 11–20 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Tyndall, A. J. et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis. 69, 1809–1815 (2010).ArticleÂ
PubMedÂ
Google ScholarÂ
Rubio-Rivas, M., Royo, C., Simeon, C. P., Corbella, X. & Fonollosa, V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 44, 208–219 (2014).ArticleÂ
PubMedÂ
Google ScholarÂ
McNearney, T. A. et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum. 57, 318–326 (2007).ArticleÂ
PubMedÂ
Google ScholarÂ
Steen, V. D. & Medsger, T. A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann. Rheum. Dis. 66, 940–944 (2007).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mouawad, J. E. & Feghali-Bostwick, C. The molecular mechanisms of systemic sclerosis-associated lung fibrosis. Int. J. Mol. Sci. 24 (2023).Rueda, B. et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum. Mol. Genet. 18, 2071–2077 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Tsuchiya, N. et al. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann. Rheum. Dis. 68, 1375–1376 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Xu, Y., Wang, W., Tian, Y., Liu, J. & Yang, R. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis. Int J. Dermatol. 55, 408–416 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dieude, P. et al. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. J. Rheumatol. 37, 987–992 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lafyatis, R. Transforming growth factor beta-at the centre of systemic sclerosis. Nat. Rev. Rheumatol. 10, 706–719 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Morris, E. et al. Endoglin promotes TGF-beta/Smad1 signaling in scleroderma fibroblasts. J. Cell Physiol. 226, 3340–3348 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Herrmann, K., Heckmann, M., Kulozik, M., Haustein, U. F. & Krieg, T. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J. Invest. Dermatol. 97, 219–222 (1991).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Garabrant, D. H. et al. Scleroderma and solvent exposure among women. Am. J. Epidemiol. 157, 493–500 (2003).ArticleÂ
PubMedÂ
Google ScholarÂ
Muntyanu, A. et al. Exposure to silica and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group. Front Med. 9, 984907 (2022).ArticleÂ
Google ScholarÂ
Shivakumar, D. S., Kamath, N. S. & Naik, A. Silica associated systemic sclerosis: an occupational health hazard. BMJ Case Rep. 16 (2023).Lescoat, A. et al. Silica exposure and scleroderma: more bridges and collaboration between disciplines are needed. Am. J. Respir. Crit. Care Med. 201, 880–882 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Garrett, S. M., Baker Frost, D. & Feghali-Bostwick, C. The mighty fibroblast and its utility in scleroderma research. J. Scleroderma Relat. Disord. 2, 69–134 (2017).PubMedÂ
Google ScholarÂ
Morrisroe, K. & Nikpour, M. Cancer and scleroderma: recent insights. Curr. Opin. Rheumatol. 32, 479–487 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Zhang, J. Q. et al. The risk of cancer development in systemic sclerosis: a meta-analysis. Cancer Epidemiol. 37, 523–527 (2013).ArticleÂ
PubMedÂ
Google ScholarÂ
Onishi, A., Sugiyama, D., Kumagai, S. & Morinobu, A. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum. 65, 1913–1921 (2013).ArticleÂ
PubMedÂ
Google ScholarÂ
Christenson, L. J. et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294, 681–690 (2005).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Weeding, E., Casciola-Rosen, L. & Shah, A. A. Cancer and Scleroderma. Rheum. Dis. Clin. North Am. 46, 551–564 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bonifazi, M. et al. Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology 52, 143–154 (2013).ArticleÂ
PubMedÂ
Google ScholarÂ
Lepri, G. et al. Systemic Sclerosis Association with Malignancy. Clin. Rev. Allergy Immunol. 63, 398–416 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mecoli, C. A., Rosen, A., Casciola-Rosen, L. & Shah, A. A. Advances at the interface of cancer and systemic sclerosis. J. Scleroderma Relat. Disord. 6, 50–57 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Hoffmann-Vold, A. M. et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am. J. Respir. Crit. Care Med. 200, 1258–1266 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Pezone, A. et al. Inflammation and DNA damage: cause, effect or both. Nat. Rev. Rheumatol. 19, 200–211 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y. & Murata, M. Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis. Int. J. Mol. Sci. 18 (2017).Kay, J., Thadhani, E., Samson, L. & Engelward, B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair. 83, 102673 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Igusa, T. et al. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Ann. Rheum. Dis. 77, 1179–1186 (2018).PubMedÂ
Google ScholarÂ
Usategui, A. et al. Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis. Immun. Ageing 19, 7 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Vlachogiannis, N. I. et al. Association between DNA damage response, fibrosis and Type I Interferon signature in systemic sclerosis. Front. Immunol. 11, 582401 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Paul, S. et al. Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis. Nat. Commun. 13, 7074 (2022).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Gniadecki, R. et al. Genomic instability in early systemic sclerosis. J. Autoimmun. 131, 102847 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122–128 (2020).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kendall, R. T. & Feghali-Bostwick, C. A. Fibroblasts in fibrosis: novel roles and mediators. Front. Pharm. 5, 123 (2014).ArticleÂ
Google ScholarÂ
Huang, L., Ma, F., Chapman, A., Lu, S. & Xie, X. S. Single-cell whole-genome amplification and sequencing: methodology and applications. Annu. Rev. Genomics Hum. Genet. 16, 79–102 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dong, X. et al. Accurate identification of single-nucleotide variants in whole-genome-amplified single cells. Nat. Methods 14, 491–493 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Saini, N. et al. UV-exposure, endogenous DNA damage, and DNA replication errors shape the spectra of genome changes in human skin. PLoS Genet. 17, e1009302 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Shinbrot, E. et al. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 24, 1740–1750 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lujan, S. A. et al. Mismatch repair balances leading and lagging strand DNA replication fidelity. PLoS Genet. 8, e1003016 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Haradhvala, N. J. et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell 164, 538–549 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Senkin, S. MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinforma. 22, 540 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Deneuve, S. et al. Molecular landscapes of oral cancers of unknown etiology. medRxiv (2023).Wu, A. J., Perera, A., Kularatnarajah, L., Korsakova, A. & Pitt, J. J. Mutational signature assignment heterogeneity is widespread and can be addressed by ensemble approaches. Brief Bioinform. 24 (2023).Huang, X., Wojtowicz, D. & Przytycka, T. M. Detecting presence of mutational signatures in cancer with confidence. Bioinformatics 34, 330–337 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Koh, G., Degasperi, A., Zou, X., Momen, S. & Nik-Zainal, S. Mutational signatures: emerging concepts, caveats and clinical applications. Nat. Rev. Cancer 21, 619–637 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Petljak, M. et al. Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC Mutagenesis. Cell 176, 1282–1294.e20 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Rouhani, F. J. et al. Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells. PLoS Genet 12, e1005932 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kuijk, E. et al. The mutational impact of culturing human pluripotent and adult stem cells. Nat. Commun. 11, 2493 (2020).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Milholland, B. et al. Differences between germline and somatic mutation rates in humans and mice. Nat. Commun. 8, 15183 (2017).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Vijayraghavan, S., Porcher, L., Mieczkowski, P. A. & Saini, N. Acetaldehyde makes a distinct mutation signature in single-stranded DNA. Nucleic Acids Res. 50, 7451–7464 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet 45, 970–976 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pham, P., Bransteitter, R., Petruska, J. & Goodman, M. F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103–107 (2003).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rogozin, I. B. et al. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Sci. Rep. 6, 38133 (2016).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics 20, 685 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Matsuda, T., Kawanishi, M., Yagi, T., Matsui, S. & Takebe, H. Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res. 26, 1769–1774 (1998).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sonohara, Y. et al. Acetaldehyde forms covalent GG intrastrand crosslinks in DNA. Sci. Rep. 9, 660 (2019).ArticleÂ
ADSÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Otlu, B. et al. Topography of mutational signatures in human cancer. Cell Rep. 42, 112930 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Roberts, S. A. et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424–435 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bergstrom, E. N., Kundu, M., Tbeileh, N. & Alexandrov, L. B. Examining clustered somatic mutations with SigProfilerClusters. Bioinformatics 38, 3470–3473 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, Y. et al. APOBEC mutagenesis is a common process in normal human small intestine. Nat. Genet 55, 246–254 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wala, J. A. et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 28, 581–591 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333–i339 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
MacDonald, J. R., Ziman, R., Yuen, R. K., Feuk, L. & Scherer, S. W. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 42, D986–D992 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Fickelscher, I. et al. The variant inv(2)(p11.2q13) is a genuinely recurrent rearrangement but displays some breakpoint heterogeneity. Am. J. Hum. Genet 81, 847–856 (2007).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tamborero, D. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 10, 25 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Olafsson, S. et al. Somatic Evolution in Non-neoplastic IBD-Affected Colon. Cell 182, 672–684.e11 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Rogozin, I. B. et al. DNA polymerase eta mutational signatures are found in a variety of different types of cancer. Cell Cycle 17, 348–355 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nada, S., Kahaleh, B. & Altorok, N. Genome-wide DNA methylation pattern in systemic sclerosis microvascular endothelial cells: Identification of epigenetically affected key genes and pathways. J. Scleroderma Relat. Disord. 7, 71–81 (2022).ArticleÂ
PubMedÂ
Google ScholarÂ
Folmsbee, S. S., Budinger, G. R. S., Bryce, P. J. & Gottardi, C. J. The cardiomyocyte protein alphaT-catenin contributes to asthma through regulating pulmonary vein inflammation. J. Allergy Clin. Immunol. 138, 123–129.e2 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2 (2022).Burgers, P. M. et al. Eukaryotic DNA polymerases: proposal for a revised nomenclature. J. Biol. Chem. 276, 43487–43490 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
McCulloch, S. D. & Kunkel, T. A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18, 148–161 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Washington, M. T., Johnson, R. E., Prakash, L. & Prakash, S. Accuracy of lesion bypass by yeast and human DNA polymerase eta. Proc. Natl Acad. Sci. USA 98, 8355–8360 (2001).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F. & Kunkel, T. A. Low fidelity DNA synthesis by human DNA polymerase-eta. Nature 404, 1011–1013 (2000).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Saini, N. et al. The impact of environmental and endogenous damage on somatic mutation load in human skin fibroblasts. PLoS Genet. 12, e1006385 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Matsuda, T. et al. Error rate and specificity of human and murine DNA polymerase eta. J. Mol. Biol. 312, 335–346 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rogozin, I. B. et al. Mutational signatures and mutable motifs in cancer genomes. Brief. Bioinform. 19, 1085–1101 (2018).CASÂ
PubMedÂ
Google ScholarÂ
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yoshida, K. et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature 578, 266–272 (2020).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S. & Engelward, B. P. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet. 11, e1004901 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470–18476 (1999).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mao, C. et al. T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity 20, 133–144 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
William, J., Euler, C., Christensen, S. & Shlomchik, M. J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297, 2066–2070 (2002).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Schroder, A. E., Greiner, A., Seyfert, C. & Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 93, 221–225 (1996).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Okazaki, I. M. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197, 1173–1181 (2003).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Casellas, R. et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat. Rev. Immunol. 16, 164–176 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, L. et al. Activation-induced cytidine deaminase expression in colorectal cancer. Int J. Clin. Exp. Pathol. 12, 4119–4124 (2019).PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nonaka, T. et al. Involvement of activation-induced cytidine deaminase in skin cancer development. J. Clin. Invest. 126, 1367–1382 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sawai, Y. et al. Activation-induced cytidine deaminase contributes to pancreatic tumorigenesis by inducing tumor-related gene mutations. Cancer Res. 75, 3292–3301 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Taylor, B. J. et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438–442 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhou, Y. et al. Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer. Cancer Cell 38, 818–828.e5 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hsu, E. et al. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum. 63, 783–794 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Renaud, L., da Silveira, W. A., Takamura, N., Hardiman, G. & Feghali-Bostwick, C. Prominence of IL6, IGF, TLR, and bioenergetics pathway perturbation in lung tissues of scleroderma patients with pulmonary fibrosis. Front. Immunol. 11, 383 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pedersen, B. S., Collins, R. L., Talkowski, M. E. & Quinlan, A. R. Indexcov: fast coverage quality control for whole-genome sequencing. Gigascience 6, 1–6 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Koboldt, D. C. Best practices for variant calling in clinical sequencing. Genome Med. 12, 91 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811–1817 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Larson, D. E. et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311–317 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gel, B. & Serra, E. karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics 33, 3088–3090 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Blokzijl, F., Janssen, R., van Boxtel, R. & Cuppen, E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 10, 33 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, H., Meltzer, P. & Davis, S. RCircos: an R package for Circos 2D track plots. BMC Bioinforma. 14, 244 (2013).ArticleÂ
Google ScholarÂ